# US 2026/0217920 A1 · Composite Nanoparticles, Compositions thereof, and Methods of Use and Manufacture

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0217920 A1
- Document ID: US20260217920A1
- Status: Published application
- Kind: A1
- Application number: 19/456,728
- Filed: 2026-01-22
- Published: 2026-07-30
- Earliest claimed: 2025-01-24
- Assignees: Van Andel Research Institute
- Applicants: Van Andel Research Institute
- Inventors: Michael Patrick Vincent
- Web page: https://patentgrep.com/patent/US20260217920A1

## CPC

- C08G 81/027: {containing polyester or polycarbonate sequences}
- A61K 9/1075: {Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence)}
- A61K 9/5123: {Organic compounds, e.g. fats, sugars}
- A61K 9/5146: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides}
- A61K 9/5153: {Polyesters, e.g. poly(lactide-co-glycolide)}
- C08K 5/101: of monocarboxylic acids
- C08K 5/3415: Five-membered rings
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08K: Use of inorganic or non-macromolecular organic substances as compounding ingredients (paints, inks, varnishes, dyes, polishes, adhesives C09)

## Abstract

A composite nanoparticle that includes a biodegradable amphiphilic material and a hydrophobic compound having a stable isotope label. The biodegradable amphiphilic material may be a polymeric, non-polymeric, or hybrid polymer/lipid self-assembling system. The composite nanoparticle may be a poly(ethylene glycol)-block-poly(ε-caprolactone) (PEG-b-PCL) copolymer, a poly(ethylene glycol)-block-poly(L-lactide) (PEG-b-PLA) copolymer, or poly(ethylene glycol)-block-poly(lactide-co-glycolide) (PEG-b-PLGA) copolymer; and the poly(ethylene glycol) block of any of the polymeric biodegradable amphiphilic copolymers may be poly(ethylene glycol) or methoxy poly(ethylene glycol). The hydrophobic compound of the composite nanoparticle may be a fatty acid, a fatty acid derivative, and a lipid analog having a stable isotope label. Compositions and methods of using and making the composite nanoparticle.

## Claims

### Claim 1

A composite nanoparticle comprising:
a biodegradable amphiphilic material; and
a hydrophobic compound, wherein the hydrophobic compound includes a stable isotope label.

### Claim 2 (depends on 1)

The composite nanoparticle of claim 1, wherein the biodegradable amphiphilic material is a polymeric, non-polymeric, or hybrid polymer/lipid self-assembling system.

### Claim 3 (depends on 1)

The composite nanoparticle of claim 1, wherein the biodegradable amphiphilic material is polymeric and is selected from the group consisting of:
a poly(ethylene glycol)-block-poly(ε-caprolactone) copolymer (PEG-b-PCL),
a poly(ethylene glycol)-block-poly(lactide) copolymer (PEG-b-PLA),
a poly(ethylene glycol)-block-poly(lactide-co-glycolide) copolymer (PEG-b-PLGA), and combinations thereof.

### Claim 4 (depends on 1)

The composite nanoparticle of claim 1, wherein the biodegradable amphiphilic material is self-assembled.

### Claim 5 (depends on 1)

The composite nanoparticle of claim 1, wherein the biodegradable amphiphilic material is a polymer blend.

### Claim 6 (depends on 1)

The composite nanoparticle of claim 1, wherein the biodegradable amphiphilic material is a tri-block copolymeric biodegradable amphiphilic material.

### Claim 7 (depends on 6)

The composite nanoparticle of claim 6, wherein the tri-block copolymer is a poly(ethylene glycol)-block-poly(lactide)-block-poly(ethylene glycol) copolymer (PEG-b-PLA-b-PEG).

### Claim 8 (depends on 1)

The composite nanoparticle of claim 1, wherein the biodegradable amphiphilic material is polymeric and is selected from the group consisting of: a poly(ethylene glycol)-block-poly(carbonate) copolymer, a poly(ethylene glycol)-block-poly(ester) copolymer, a poly(ethylene glycol)-block-poly(amino acid) copolymer, a poly(ethylene glycol)-block-poly(beta-amino ester) copolymer, a poly(ethylene glycol)-block-poly(ortho ester) copolymer, and combinations thereof.

### Claim 9 (depends on 1)

The composite nanoparticle of claim 1, wherein the biodegradable amphiphilic material is formed into a micelle, liposome, lipid nanoparticle (LNP), or polymersome.

### Claim 10 (depends on 1)

The composite nanoparticle of claim 1, wherein the biodegradable amphiphilic material is a non-polymeric or a hybrid polymer/lipid self-assembling system.

### Claim 11 (depends on 10)

The composite nanoparticle of claim 10, wherein the biodegradable amphiphilic material is non-polymeric and is selected from the group consisting of: a phospholipid, an ionizable lipid, a cationic lipid, a neutral lipid, cholesterol, and combinations thereof.

### Claim 12 (depends on 1)

The composite nanoparticle of claim 1, wherein the biodegradable amphiphilic material includes a hydrophilic segment and a hydrophobic segment.

### Claim 13 (depends on 12)

The composite nanoparticle of claim 12, wherein the hydrophilic segment is poly(ethylene glycol).

### Claim 14 (depends on 13)

The composite nanoparticle of claim 13,
wherein the poly(ethylene glycol) is terminated with a moiety selected from the group consisting of a hydroxyl group (—OH), a methyl group (—CH3), a phosphate group (—PO4), an amine group (—NH2), a carboxyl group (—CO2H), a thiol group (—SH), an aldehyde group (—CHO), a vinyl group (—C2H3), an epoxide group, a malemide group, and an azide group (N3).

### Claim 15 (depends on 2)

The composite nanoparticle of claim 2, wherein the poly(ethylene glycol) is methoxy poly(ethylene glycol).

### Claim 16 (depends on 12)

The composite nanoparticle of claim 12, wherein the hydrophobic segment is selected from the group consisting of poly(ε-caprolactone), poly(lactide), and poly(lactide-co-glycolide).

### Claim 17 (depends on 16)

The composite nanoparticle of claim 16, wherein hydrophobic segment is poly(lactide) in the form of poly(L-lactide), poly(D-lactide), poly(D,L-lactide), or combinations thereof.

### Claim 18 (depends on 16)

The composite nanoparticle of claim 16, wherein the hydrophobic segment is poly(lactide-co-glycolide) and the lactide component is in the form of poly(L-lactide), poly(D-lactide), poly(D,L-lactide), or combinations thereof.

### Claim 19 (depends on 12)

The composite nanoparticle of claim 12, wherein the hydrophobic segment is selected from the group consisting of: an aliphatic polyester, a polycarbonate, a polyether, a polyurethane, and a lipid tail.

### Claim 20 (depends on 1)

The composite nanoparticle of claim 1, wherein the hydrophobic compound is selected from the group consisting of a fatty acid, a fatty acid derivative, and a lipid analog.

### Claim 21 (depends on 1)

The composite nanoparticle of claim 1, wherein the hydrophobic compound is selected from the group consisting of palmitate, palmitic acid, palmitoleate, oleate, oleic acid, stearate, linoleate, linolenate, arachidonate, glycerol, triolein, tripalmitin, triglycerides, cholesterol, acetate, choline, ethanolamine, mevalonate, isoprenoids, ceramides, sphingolipids, and a metabolite.

### Claim 22 (depends on 21)

The composite nanoparticle of claim 21, wherein the hydrophobic compound is palmitate or oleic acid.

### Claim 23 (depends on 22)

The composite nanoparticle of claim 22, wherein the hydrophobic compound is palmitate.

### Claim 24 (depends on 23)

The composite nanoparticle of claim 23, wherein the biodegradable amphiphilic material is PEG-b-PCL.

### Claim 25 (depends on 23)

The composite nanoparticle of claim 23, wherein the biodegradable amphiphilic material is PEG-b-PLA.

### Claim 26 (depends on 23)

The composite nanoparticle of claim 23, wherein the biodegradable amphiphilic material is PEG-b-PLGA.

### Claim 27 (depends on 1)

The composite nanoparticle of claim 1, wherein the stable isotope label of the hydrophobic compound is selected from the group consisting of carbon-13 (13C), hydrogen-2 (2H), nitrogen-15 (15N), and oxygen-18 (18O).

### Claim 28 (depends on 23)

The composite nanoparticle of claim 23, wherein the stable isotope label of the hydrophobic compound is 13C.

### Claim 29 (depends on 28)

The composite nanoparticle of claim 28, wherein the hydrophobic compound is U-13C-palmitate.

### Claim 30 (depends on 1)

The composite nanoparticle of claim 1, further comprising a hydrophobic fluorescent dye.

### Claim 31 (depends on 1)

The composite nanoparticle of claim 1, wherein the composite nanoparticle has an average diameter in a range from about 20 nm to about 400 nm.

### Claim 32 (depends on 31)

The composite nanoparticle of claim 31, wherein the average diameter is in the range from about 20 nm to about 50 nm.

### Claim 33 (depends on 1)

The composite nanoparticle of claim 1, wherein composite nanoparticle has a surface zeta potential in a range from about −50 mV to about +50 mV.

### Claim 34 (depends on 33)

The composite nanoparticle of claim 33, wherein the surface zeta potential is in the range from about −20 mV to about −10 mV.

### Claim 35

A composition, comprising:
a plurality of composite nanoparticles,
wherein each composite nanoparticle of the plurality of composite nanoparticles includes a biodegradable amphiphilic material and a hydrophobic compound, and
wherein the hydrophobic compound includes a stable isotope label.

### Claim 36 (depends on 35)

A pharmaceutical composition, comprising:
the composition of claim 35; and
a pharmaceutically acceptable carrier.

### Claim 37

A method of following a hydrophobic compound through a biochemical pathway in a cell, comprising the steps of:
providing the cell;
providing a composite nanoparticle, wherein the composite nanoparticle includes a biodegradable amphiphilic material and a hydrophobic compound, and wherein the hydrophobic compound includes a stable isotope label;
delivering an effective amount of the composite nanoparticle to the cell; and
following the hydrophobic compound through the biochemical pathway in the cell.

### Claim 38 (depends on 37)

The method of claim 37, wherein the biochemical pathway is selected from the group consisting of central carbon metabolism, lipid biosynthesis, lipid remodeling, lipid transport, and any associated pathway involving the hydrophobic compound or products formed through the participation of the hydrophobic compound in one or more biological reactions.

### Claim 39

A method of tracking internalization of a hydrophobic compound in a cell, comprising the steps of:
providing the cell;
providing a composite nanoparticle, wherein the composite nanoparticle includes a biodegradable amphiphilic material and a hydrophobic compound, and wherein the hydrophobic compound includes a stable isotope label;
delivering an effective amount of the composite nanoparticle to the cell; and
tracking internalization of the hydrophobic compound by the cell.

### Claim 40

A method of tracking distribution of a hydrophobic compound in a biological organ or tissue, comprising the steps of:
providing the biological organ or tissue;
providing a composite nanoparticle; wherein the composite nanoparticle includes a biodegradable amphiphilic material and a hydrophobic compound, and wherein the hydrophobic compound includes a stable isotope label
delivering an effective amount of the composite nanoparticle to the biological organ or tissue; and
tracking distribution of the hydrophobic compound in the biological organ or tissue.

### Claim 41 (depends on 35)

A method of diagnosing a condition or a disease in a subject, comprising the steps of:
providing the composition of claim 35;
administering a diagnostically effective amount of the composition to the subject, or a cell or tissue of the subject; and
tracking the movement, incorporation, or metabolic effect of the hydrophobic compound in the subject, cell, or tissue.

### Claim 42

A method of making a composite nanoparticle, wherein the composite nanoparticle includes a biodegradable amphiphilic material and a hydrophobic compound, and wherein the hydrophobic compound includes a stable isotope label, the method comprising the steps of:
providing the biodegradable material copolymer and the hydrophobic compound, and loading the hydrophobic compound into the biodegradable amphiphilic material during or after the self-assembly of the biodegradable amphiphilic material or
providing the biodegradable amphiphilic material and the hydrophobic compound, and loading the hydrophobic compound into the biodegradable amphiphilic material after the self-assembly of the biodegradable amphiphilic material.
